Kerstin Huebner

The activating transcription factor 2: an influencer of cancer progression

R. Schneider-Stock, J. Procházka, K. Huebner, 2019, Mutagenesis.

A partial epithelial‐mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction

A. Naccarati, R. Schneider-Stock, Philipp Kunze, 2024, The Journal of pathology.

A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer

A. Hartmann, R. Schneider-Stock, A. Berninger, 2021, Cancers.

Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and Senescence

T. Gudermann, S. Singer, R. Schneider-Stock, 2021, Cancers.

ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2

Sushmita Paul, R. Schneider-Stock, J. Tureckova, 2022, Cellular and Molecular Life Sciences.

Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma.

R. Schneider-Stock, A. Agaimy, H. Gali-Muhtasib, 2015, Cancer letters.

ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway

R. Schneider-Stock, Han Yang, C. Geppert, 2023, BMC Cancer.